Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-07-13

Clinical Trial Update: Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial for levothyroxine in subclinical hypothyroidism after head and neck surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levothyroxine (levothyroxine)

Snippet

Sponsor: University of Alberta | Conditions: Hypothyroidism, Neoplasms | Phase 2, Phase 3 | Status: WITHDRAWN